Campbell Rogers

Filings by Campbell Rogers span 3 companies, the busiest being Heartflow, Inc., InspireMD, Inc. and Corindus Vascular Robotics, Inc. Between 26 January 2016 and 18 September 2026, the trades on record add up to 30 filings.

The open-market side counts 1 purchase for €4,433 alongside 5 sales for €4.2M. Sales outweigh purchases by €4.2M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 13 share grants and 10 option exercises. Since January 2026: no purchases and 5 sales on the market.

The latest filing, published on 21 September 2026, reports an open-market sale of €860k in Heartflow, Inc. The clock since the last published purchase (23 March 2016) now reads 3,866 days. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.